Lanean...

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins

Lowering of low-density lipoprotein cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) is clearly efficacious in the treatment and prevention of coronary artery disease. However, despite increasing use of statins, a significant number of coronary events still occur...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tenenbaum, Alexander, Fisman, Enrique Z, Motro, Michael, Adler, Yehuda
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2006
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1592077/
https://ncbi.nlm.nih.gov/pubmed/17002798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-5-20
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!